Next Article in Journal
Feasibility Trial Exploring Immune-Related Biomarkers Pertaining to Rapid Immune Surveillance and Cytokine Changes after Consuming a Nutraceutical Supplement Containing Colostrum- and Egg-Based Low-Molecular-Weight Peptides
Previous Article in Journal
Potential New Inflammatory Markers in Bronchiectasis: A Literature Review
Previous Article in Special Issue
MAFLD Pandemic: Updates in Pharmacotherapeutic Approach Development
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Review

Common Denominator of MASLD and Some Non-Communicable Diseases

by
Katarzyna Ferenc
1,
Sara Jarmakiewicz-Czaja
2,
Aneta Sokal-Dembowska
2,
Katarzyna Stasik
1,3 and
Rafał Filip
1,3,*
1
Institute of Medicine, Medical College of Rzeszow University, 35-959 Rzeszow, Poland
2
Institute of Health Sciences, Medical College of Rzeszow University, 35-959 Rzeszow, Poland
3
Department of Gastroenterology with IBD Unit, Clinical Hospital No. 2, 35-301 Rzeszow, Poland
*
Author to whom correspondence should be addressed.
Curr. Issues Mol. Biol. 2024, 46(7), 6690-6709; https://doi.org/10.3390/cimb46070399 (registering DOI)
Submission received: 28 May 2024 / Revised: 25 June 2024 / Accepted: 27 June 2024 / Published: 29 June 2024
(This article belongs to the Special Issue Cellular and Molecular Mechanisms of Nonalcoholic Fatty Liver Disease)

Abstract

Currently, steatohepatitis has been designated as metabolic dysfunction-associated steatohepatitis (MASLD). MASLD risk factors mainly include metabolic disorders but can also include genetic, epigenetic, and environmental factors. Disease entities such as obesity, diabetes, cardiovascular disease, and MASLD share similar pathomechanisms and risk factors. Moreover, a bidirectional relationship is observed between the occurrence of certain chronic diseases and MASLD. These conditions represent a global public health problem that is responsible for poor quality of life and high mortality. It seems that paying holistic attention to these problems will not only help increase the chances of reducing the incidence of these diseases but also assist in the prevention, treatment, and support of patients.
Keywords: cardiovascular diseases; diabetes; liver cancer; obesity; steatotic liver disease cardiovascular diseases; diabetes; liver cancer; obesity; steatotic liver disease

Share and Cite

MDPI and ACS Style

Ferenc, K.; Jarmakiewicz-Czaja, S.; Sokal-Dembowska, A.; Stasik, K.; Filip, R. Common Denominator of MASLD and Some Non-Communicable Diseases. Curr. Issues Mol. Biol. 2024, 46, 6690-6709. https://doi.org/10.3390/cimb46070399

AMA Style

Ferenc K, Jarmakiewicz-Czaja S, Sokal-Dembowska A, Stasik K, Filip R. Common Denominator of MASLD and Some Non-Communicable Diseases. Current Issues in Molecular Biology. 2024; 46(7):6690-6709. https://doi.org/10.3390/cimb46070399

Chicago/Turabian Style

Ferenc, Katarzyna, Sara Jarmakiewicz-Czaja, Aneta Sokal-Dembowska, Katarzyna Stasik, and Rafał Filip. 2024. "Common Denominator of MASLD and Some Non-Communicable Diseases" Current Issues in Molecular Biology 46, no. 7: 6690-6709. https://doi.org/10.3390/cimb46070399

Article Metrics

Back to TopTop